CEA

Clear Comfort Unveils the CCW2000 Series for the Ultimate Controlled Environment Agriculture (CEA) AOP-Driven™ Water Treatment

Retrieved on: 
Tuesday, November 28, 2023

LOUISVILLE, Colo., Nov. 28, 2023 /PRNewswire-PRWeb/ -- Clear Comfort launched the CCW2000 Series, a historic advancement in controlled environment agriculture (CEA) water treatment. Powered by patented Hydroxyl-Based Advanced Oxidation Process (AOP) and Dissolved Oxygen (DO) technology, the CCW2000 Series delivers the highest standards of water efficiency, quality and plant nutrient delivery. 

Key Points: 
  • Available Now, the CCW2000 Series Introduces Fertigation-Ready™ Water Treatment for Unparalleled Growth, Profitability and Sustainability for Indoor Growing
    LOUISVILLE, Colo., Nov. 28, 2023 /PRNewswire-PRWeb/ -- Clear Comfort launched the CCW2000 Series, a historic advancement in controlled environment agriculture (CEA) water treatment.
  • "Innovative technologies, like Clear Comfort's AOP-Driven water treatment, are precisely what our industry needs to fuel a new era of growth."
  • "Our commitment to redefining sustainable water treatment solutions is rooted in listening and learning from the market and our customers.
  • The CCW2000 AOP-Driven DO™ Series for CEA water treatment is available for order now.

Linux Foundation Announces Intent to Form the High Performance Software Foundation

Retrieved on: 
Monday, November 13, 2023

SAN FRANCISCO, Nov. 13, 2023 /PRNewswire/ -- Today, the Linux Foundation, the nonprofit organization enabling mass innovation through open source, announced the intention to form the High Performance Software Foundation (HPSF). Through a series of technical projects, HPSF aims to build, promote, and advance a portable software stack for high performance computing (HPC) by increasing adoption, lowering barriers to contribution, and supporting development efforts.

Key Points: 
  • Foundation aims to build, promote, and advance a portable core software stack for high performance computing.
  • SAN FRANCISCO, Nov. 13, 2023 /PRNewswire/ -- Today, the Linux Foundation, the nonprofit organization enabling mass innovation through open source, announced the intention to form the High Performance Software Foundation (HPSF).
  • Foundation aims to build, promote, and advance a portable core software stack for high performance computing.
  • As an umbrella project under the Linux Foundation, HPSF intends to provide a neutral space for pivotal projects in the high performance software ecosystem, enabling industry, academia, and government entities to collaborate together on the scientific software stack.

SilverCrest Reports Third Quarter 2023 Results

Retrieved on: 
Wednesday, November 8, 2023

In the third quarter, total cost of sales was $26.4 million (Q2, 2023 - $23.7 million), an increase of 11% over Q2, 2023.

Key Points: 
  • In the third quarter, total cost of sales was $26.4 million (Q2, 2023 - $23.7 million), an increase of 11% over Q2, 2023.
  • During Q3, 2023, sustaining capital expenditure of $9.8 million was a decrease from Q2, 2023 of $0.3 million and below plan for the quarter.
  • The Company anticipates its capital spending at Las Chispas to increase in Q4, 2023 relative to Q3, 2023 and remain within 2023 AISC guidance.
  • A conference call to discuss the Company's Q3, 2023 operational and financial results will be held Thursday November 9, 2023 at 8:00 a.m. PT / 11:00 a.m.

Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

Retrieved on: 
Tuesday, November 7, 2023

ET

Key Points: 
  • ET
    SCOTTSDALE, Ariz., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”) approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced financial results and recent corporate highlights for the third quarter ended September 30, 2023.
  • We are also extremely pleased with the positive topline results from our two Phase 3 clinical trials evaluating DFD-29 for the treatment of rosacea.
  • Selling, general and administrative expenses (“SG&A”) decreased by $7.0 million, or 45%, to $8.6 million for the third quarter of 2023, from $15.6 million for the third quarter 2022.
  • Research and Development (“R&D”) expenses decreased by $0.6 million, or 21%, to $2.2 million for the third quarter of 2023, from $2.8 million for the third quarter 2022.

InspireMD Reports Third Quarter 2023 Financial Results and Provides Business Update

Retrieved on: 
Monday, November 6, 2023

TEL AVIV, Israel and MIAMI, Nov. 06, 2023 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for treatment of carotid artery disease and prevention of stroke today announced financial results and business updates for the third quarter ended September 30, 2023.

Key Points: 
  • Generated CGuard revenue for the third quarter 2023 of $1,556,072, an 8.8 % increase over the same period in 2022.
  • Sold 2,734 CGuard EPS stent systems in the third quarter of 2023, as compared to 2,624 in the third quarter of 2022, an increase of 4.2 %.
  • Total financial income for the third quarter of 2023 was $461,000, an increase of $380,000 or 469% compared to $81,000 for the third quarter of 2022.
  • Management will host a conference call today, Monday, November 6th, at 8:30 AM ET, to review financial results and provide an update on corporate developments.

Edible Garden Schedules Third Quarter 2023 Financial Results and Business Update Conference Call

Retrieved on: 
Monday, November 6, 2023

BELVIDERE, NJ, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic and sustainable produce and products, announced today that it will host a conference call on Monday, November 13, 2023, at 8:00 AM Eastern Time to discuss financial results for the quarter ended September 30, 2023, and provide a business update.

Key Points: 
  • BELVIDERE, NJ, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic and sustainable produce and products, announced today that it will host a conference call on Monday, November 13, 2023, at 8:00 AM Eastern Time to discuss financial results for the quarter ended September 30, 2023, and provide a business update.
  • The conference call will be available via telephone by dialing toll-free +1 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and entering access code 174900.
  • A webcast of the call may be accessed at https://www.webcaster4.com/Webcast/Page/2914/49437 or on the investor relations section of the company’s website, https://ediblegardenag.com/presentations/ .
  • A webcast replay will be available on the investor relations section of the Company’s website at https://ediblegardenag.com/presentations/ through November 13, 2024.

Edible Garden Available at Tops Friendly Markets; Expands Company’s Distribution Network in New York, Pennsylvania, and Vermont

Retrieved on: 
Monday, October 30, 2023

Mr. Jim Kras, Chief Executive Officer of Edible Garden, stated, "We are pleased to announce that Tops Friendly Markets will now feature our sustainable herbs throughout their 149 retail locations in New York, Pennsylvania, and Vermont.

Key Points: 
  • Mr. Jim Kras, Chief Executive Officer of Edible Garden, stated, "We are pleased to announce that Tops Friendly Markets will now feature our sustainable herbs throughout their 149 retail locations in New York, Pennsylvania, and Vermont.
  • Their addition to our already robust distribution network enhances the Company’s presence in the Northeastern United States.
  • We trust that Tops Friendly Markets will recognize Edible Garden as a go-to, dependable source of produce, and our objective is to expand our offering over time.
  • We look forward to enjoying a long relationship with Tops Friendly Markets, providing them with the reliable service and high-quality products that their customers can count on.”

A2 Bio Presents Oral and Poster Presentations Highlighting BASECAMP-1 and EVEREST-1 Patient Screening at 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Retrieved on: 
Thursday, November 2, 2023

Additionally, A2 Bio is presenting two posters on November 4, 2023, detailing the BASECAMP-1 master pre-screening trial and EVEREST-1 CAR T interventional trial.

Key Points: 
  • Additionally, A2 Bio is presenting two posters on November 4, 2023, detailing the BASECAMP-1 master pre-screening trial and EVEREST-1 CAR T interventional trial.
  • “BASECAMP-1 provides patients an early opportunity to be identified and triaged to the appropriate EVEREST logic-gate Tmod™ CAR T trial.
  • A2 Bio has partnered with Tempus, a leader in precision medicine, to bring the latest technology to patient screening.
  • Details of the presentations are below:
    The two posters will be available on the A2 Bio website after November 4, 2023.

Pacifico Aquaculture Receives Significant Investment to Support Nursery Build-Out and Sustainable Aquaculture Expansion

Retrieved on: 
Wednesday, November 1, 2023

Pacifico Aquaculture (“Pacifico”), a leader in sustainable aquaculture, announced today that it has received project financing from Equilibrium Capital (“Equilibrium”), in addition to a significant equity investment from a consortium led by Butterfly Equity (“Butterfly”) and a leading U.S. public pension fund.

Key Points: 
  • Pacifico Aquaculture (“Pacifico”), a leader in sustainable aquaculture, announced today that it has received project financing from Equilibrium Capital (“Equilibrium”), in addition to a significant equity investment from a consortium led by Butterfly Equity (“Butterfly”) and a leading U.S. public pension fund.
  • A pioneer in sustainable aquaculture in North America, Pacifico is also the first marine fish farm in Mexico to obtain a four-star Best Aquaculture Practices (BAP) certification , the highest designation in the BAP program.
  • Billund Aquaculture will supply the recirculating aquaculture system (RAS) technology for the nursery.
  • We cannot be more excited to partner with Equilibrium who shares our vision to build Pacifico into a world-class aquaculture platform under Per-Roar’s strong leadership.”

Edible Garden Receives USDA Grant for Organic Certification Costs for its Belvidere, New Jersey Facility

Retrieved on: 
Monday, October 23, 2023

These funds are designated to reimburse organic producers and handlers with financial assistance to reduce the costs associated with organic certification, as well as processing/handling certifications.

Key Points: 
  • These funds are designated to reimburse organic producers and handlers with financial assistance to reduce the costs associated with organic certification, as well as processing/handling certifications.
  • Mr. Jim Kras, Chief Executive Officer of Edible Garden, commented, "We are pleased to receive this grant from the USDA’s Organic Certification Program, overseen by the Farm Service Agency.
  • The grant provides reimbursement for a number of the costs associated with our organic crop certification, and related costs at our Belvidere, New Jersey facility.
  • Earlier this year, our Grand Rapids, Michigan-based Edible Garden Heartland facility also received a similar grant.